English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, December 20, 2017
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market
雅各臣科研制药与上海复宏汉霖订立协议 进军生物制剂市场
雅各臣科研製藥與上海復宏漢霖訂立協議 進軍生物製劑市場
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market
Wednesday, November 22, 2017
雅各臣公布二零一八财年中期业绩
雅各臣公佈二零一八財年中期業績
Jacobson Pharma Announces FY2018 Interim Results
Tuesday, October 3, 2017
雅各臣完成发行本金总额为5亿港元的可换股票据予Dragons 615 Limited及HH InRe JP, Ltd.
雅各臣完成發行本金總額為5億港元的可換股票據予Dragons 615 Limited及HH InRe JP, Ltd.
Jacobson Pharma Issues HK$500M Convertible Notes to Dragons 615 Ltd and HH InRe JP, Ltd.

Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575